cholera toxin
Biologicalexperimental
Cholera toxin is a potent enterotoxin produced by the bacterium Vibrio cholerae which causes severe watery diarrhea and dehydration that define cholera infections. The toxin is a member of the heat-labile enterotoxin family, and exists as an AB5 multimeric toxin with one enzymatically active A subunit and five receptor-binding B subunits that facilitate host cell entry. — Wikipedia
Clinical trial activity
1 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Apr 1, 2006 (NCT00820144)
Timeline
2000s
- Jan 1, 2006
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Toll-like receptor 4AGONIST
TLR4 agonist
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Sources
- WikipediaCholera toxin ↗
Also known as
- cholera toxin
- cholera toxin b
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT00820144 | Phase 1 | Apr 1, 2006 | University of Nice Sophia Antipolis |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| University of Nice Sophia Antipolis | Academic/Hospital | 1 | 1 | 1 | 2006 |
1 organizations
Page 1 / 1